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Objectives The aim of this study was to determine the diagnostic performance of a new method for quantifying fractional
flow reserve (FFR) with computational fluid dynamics (CFD) applied to coronary computed tomography angiogra-
phy (CCTA) data in patients with suspected or known coronary artery disease (CAD).
Background Measurement of FFR during invasive coronary angiography is the gold standard for identifying coronary artery
lesions that cause ischemia and improves clinical decision-making for revascularization. Computation of FFR
from CCTA data (FFRCT) provides a noninvasive method for identifying ischemia-causing stenosis; however, the
diagnostic performance of this new method is unknown.
Methods Computation of FFR from CCTA data was performed on 159 vessels in 103 patients undergoing CCTA, inva-
sive coronary angiography, and FFR. Independent core laboratories determined FFRCT and CAD stenosis se-
verity by CCTA. Ischemia was defined by an FFRCT and FFR 0.80, and anatomically obstructive CAD was
defined as a CCTA with stenosis 50%. Diagnostic performance of FFRCT and CCTA stenosis was assessed
with invasive FFR as the reference standard.
Results Fifty-six percent of patients had 1 vessel with FFR 0.80. On a per-vessel basis, the accuracy, sensitivity, specificity,
positive predictive value, and negative predictive value were 84.3%, 87.9%, 82.2%, 73.9%, 92.2%, respectively, for
FFRCT and were 58.5%, 91.4%, 39.6%, 46.5%, 88.9%, respectively, for CCTA stenosis. The area under the receiver-
operator characteristics curve was 0.90 for FFRCT and 0.75 for CCTA (p  0.001). The FFRCT and FFR were well corre-
lated (r  0.717, p  0.001) with a slight underestimation by FFRCT (0.022  0.116, p  0.016).
Conclusions Noninvasive FFR derived from CCTA is a novel method with high diagnostic performance for the detection and
exclusion of coronary lesions that cause ischemia. (The Diagnosis of ISChemia-Causing Stenoses Obtained Via
NoninvasivE FRactional FLOW Reserve; NCT01189331) (J Am Coll Cardiol 2011;58:1989–97) © 2011 by the
American College of Cardiology Foundation
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Lesion-Specific Ischemia From FFR Computed From CT November 1, 2011:1989–97Large-scale randomized trials
have demonstrated that frac-
tional flow reserve (FFR)—or
the ratio of maximal myocardial
blood flow through a diseased
artery to the blood flow in the
hypothetical case that this artery
is normal—is a useful physiolog-
ical test for assessment of lesion-
specific ischemia and a valuable
adjunct to anatomic assessment
of coronary artery disease (CAD)
as determined by invasive coronary
angiography (ICA) (1–4). This
combined anatomic-physiological
evaluation of CAD allows for en-
hanced clinical decision-making that
improves event-free survival, reduces
unnecessary revascularization, and
lowers healthcare costs (5,6).
Coronary computed tomo-
graphic angiography (CCTA) has
emerged as a noninvasive test that
assesses anatomic CAD stenosis severity (7). Although prior
multicenter studies have demonstrated favorable diagnostic
performance for CCTA identification and exclusion of ana-
tomically obstructive coronary stenoses, CAD stenosis by
CCTA demonstrates an unreliable relationship to lesion-
specific ischemia, with the majority of high-grade stenoses
detected by CCTA not causal of ischemia (8–11). These
findings have raised concerns that widespread use of CCTA
might result in excess referral of patients to ICA and unnec-
essary revascularization of nonischemic coronary lesions
(12,13).
See page 1998
Computational fluid dynamics (CFD), as applied to CCTA
images, represents a novel method that enables prediction
of blood flow and pressure fields in coronary arteries and
calculation of lesion-specific FFR (14–16). The FFR can be
computed from typically acquired CCTA scans (FFRCT)
without any modification of CCTA protocols, additional
image acquisition, or administration of medications.
We performed a prospective multicenter study to com-
pare the diagnostic performance of FFRCT with CCTA
tenosis for the diagnosis of lesion-specific ischemia, as
etermined by FFR performed at the time of ICA.
ethods
tudy design. The DISCOVER-FLOW (Diagnosis of
SChemia-Causing Stenoses Obtained Via NoninvasivE
Ractional FLOW Reserve) study was conducted at 4 sites
Seoul National University Hospital, Seoul, Korea; Pauls
Abbreviations
and Acronyms
AUC  area under the
receiver-operator
characteristics curve
CABG  coronary artery
bypass surgery
CAD  coronary artery
disease
CCTA  coronary
computed tomographic
angiography
CFD  computational fluid
dynamics
FFR  fractional flow
reserve
FFRCT  computation of
fractional flow reserve from
coronary computed
tomographic angiography
data
ICA  invasive coronary
angiographytradins Clinical University Hospital, Riga, Latvia; Injeniversity Ilsan Paik Hospital, Goyang, Korea; Stanford
niversity Medical Center, Palo Alto, California). The
tudy protocol was approved by the Institutional Review
oards of each center. The study was funded by Heartflow,
nc. (Redwood City, California).
tudy population. The study population comprised 103
table patients with suspected or known CAD who under-
ent CCTA, ICA, and FFR between October 13, 2009,
nd January 14, 2011. Inclusion criteria were: adult 18
ears of age, CCTA with 50% stenosis in a major
oronary artery 2.0 mm diameter (determined by clinical
ite), and undergoing clinically indicated ICA with FFR.
xclusion criteria included individuals unable to provide
nformed consent; noncardiac illness with life expectancy
2 years; pregnant state; allergy to iodinated contrast;
erum creatinine 1.7 mg/dl; significant arrhythmia; heart
ate 100 beats/min; systolic blood pressure 90 mm Hg;
contraindication to beta blockers, nitroglycerin or adeno-
sine; prior coronary artery bypass surgery (CABG); Cana-
dian Cardiovascular Society class IV angina; or non-
evaluable CCTA as determined by the CCTA core
laboratory. Importantly, every evaluable CCTA as judged by
the CCTA core laboratory was interpreted in independent
blinded fashion by the FFRCT core laboratory in an intent-
to-diagnose fashion.
Protocol for CCTA. Each center performed CCTA in
accordance with the Society of Cardiovascular Computed
Tomography Guidelines on Performance of CCTA with a
variety of different computed tomography scanner platforms
(Lightspeed VCT, GE Healthcare, Milwaukee, Wisconsin;
Somatom Sensation and Definition CT, Siemens, Forch-
heim, Germany; Brilliance 256 and 64, Philips, Surrey,
United Kingdom; Aquilion One and 64, Toshiba, Otawara,
Japan) (17). Intravenous or oral metoprolol was adminis-
tered for any patient with a heart rate 65 beats/min.
Immediately before image acquisition, 0.2 mg sublingual
nitroglycerin was administered. During acquisition, 80 to
100 cc of contrast (Isovue 370 mg/dl, Bracco, Princeton,
New Jersey; Omnipaque 350 mg/dl, GE Healthcare,
Princeton, New Jersey; Visipaque 320 mg/dl, GE Health-
care) was injected, followed by a saline flush. Helical or axial
scan data were obtained with retrospective or prospective
electrocardiographic gating, respectively. Image acquisition
was prescribed to include the coronary arteries, left ventricle,
and proximal ascending aorta. The scan parameters were: 64 
0.625/0.750 mm collimation, tube voltage 100 or 120 mV,
effective 400 to 650 mA. Radiation dose reduction strategies were
employed when feasible, and doses ranged from 3 to 15 mSv.
Noninvasive coronary artery analysis by CCTA. The
CCTAs were analyzed in blinded fashion by an independent
core laboratory (CVCTA, San Francisco, California) in accor-
dance with the Society of Cardiovascular Computed Tomog-
raphy guidelines on CCTA interpretation (18). The CCTA
images were evaluated with 3-dimensional workstations (Vital
Images, Minneapolis, Minnesota; Ziosoft, Redwood City,
California). The CCTAs were visualized by any post-
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November 1, 2011:1989–97 Lesion-Specific Ischemia From FFR Computed From CTprocessing method, including axial, multiplanar reformat, max-
imum intensity projection, and cross-sectional analysis.
Coronary segments were scored in a semi-quantitative
manner with an 18-segment Society of Cardiovascular
Computed Tomography model. In each segment, athero-
sclerosis was defined as tissue structures 1 mm2 that
xisted within the coronary artery lumen or adjacent to the
oronary lumen that could be discriminated from pericardial
issue, epicardial fat, or vessel lumen itself. Coronary lesions
ere quantified for luminal diameter stenosis as none (0%),
ild (1% to 49%), moderate (50% to 69%), or severe
70%). Anatomically obstructive CAD by CCTA was
efined at 2 thresholds (50% or 70% stenosis severity)
n a per-patient and per-vessel basis.
CA image acquisition and FFR performance. Selective
CA was performed by standard catheterization in accor-
ance with the American College of Cardiology Guidelines
or Coronary Angiography (19). Two projections were
btained/major epicardial vessel, with angles of projection
ptimized on the basis of cardiac position. The FFR was
erformed in vessels as clinically indicated but was not
erformed for subtotal (99% stenosis) lesions. After admin-
stration of nitroglycerin, a pressure-monitoring guidewire
PressureWire Certus, St. Jude Medical Systems, Uppsala,
weden; ComboWire, Volcano Corporation, San Diego,
alifornia) was advanced past the stenosis. Hyperemia was
ttained by administration of intravenous (140 g/kg/min,
n  90) or intracoronary (50 g, n  13) adenosine, with
route of administration at the discretion of the operator
(20). The position of the distal pressure sensor was recorded
to enable the FFRCT to be calculated from the same point
s the measured FFR. The FFR was calculated by dividing
he mean distal coronary pressure by the mean aortic
ressure during hyperemia. The FFR was considered diag-
ostic of ischemia at a threshold of 0.80 on a per-patient
nd per-vessel basis (3).
FRCT interpretation. The FFRCT was performed in
blinded fashion by core laboratory scientists at HeartFlow,
Inc. (Redwood City, California). Three-dimensional mod-
els of the coronary tree and ventricular myocardium were
reconstructed with custom methods applied to blinded
CCTA data for simulation of coronary flow and pressure
(14). Blood was modeled as a Newtonian fluid with incom-
pressible Navier-Stokes equations and solved subject to
appropriate initial and boundary conditions with a finite
element method on a parallel supercomputer. Because
coronary flow and pressure are unknown a priori, a method
to couple lumped parameter models of the microcirculation
to the outflow boundaries of the 3-D model was used (21).
The FFRCT analyses required approximately 5 h/exam;
iterative improvements in automation are expected to re-
duce processing time.
The FFRCT technology is based on 3 key principles.
ecause patients with rest angina were excluded, the first is
hat coronary supply meets myocardial demand at rest.
dherence to this principle enabled calculation of totalesting coronary flow relative to ventricular mass. The
econd principle is that resistance of the microcirculation at
est is inversely but not linearly proportional to the size of
he feeding vessel (22–26). The third principle is that
icrocirculation reacts predictably to maximal hyperemic
onditions in patients with normal coronary flow (27). On
he basis of these principles, a lumped parameter model
epresenting the resistance to flow during simulated hyper-
mia was applied to each coronary branch of the segmented
CTA model. The FFRCT was modeled for conditions of
adenosine-induced hyperemia; an FFRCT 0.80 was con-
idered diagnostic of lesion-specific ischemia.
The FFRCT core laboratory scientists were instructed as to
he location within a coronary artery where the FFR was
eported by an independent scientist who interpreted both the
CTA and ICA and who was not involved in the CCTA,
CA, FFRCT, or FFR analyses. The FFRCT core laboratory
cientists interpreted all CCTAs judged evaluable by an inde-
endent blinded reader in an intent-to-diagnose fashion.
ample size calculation and statistical analyses. The
iagnostic accuracy of CCTA stenosis 50% for the detec-
ion of lesion-specific ischemia as compared with FFR was
stimated to be 49% (11). To detect a relative improvement
n diagnostic accuracy of 25% for FFRCT as compared
ith CCTA stenosis, 150 vessels provided 90% power with
2-sided alternative hypothesis. For estimation of power,
e employed McNemar’s test to account for the paired
ature of the data and assumed independence of lesion-
pecific ischemia in vessels and a 22% rate of discordance
etween FFRCT and FFR.
Categorical variables are presented as frequencies and
percentages, with continuous variables as mean  SD.
iagnostic measures on a per-patient and -vessel basis were
alculated, including sensitivity, specificity, positive predic-
ive value (PPV), negative predictive value (NPV), accuracy,
ositive likelihood ratio, and negative likelihood ratio. The
rea under the receiver-operator characteristics curve
AUC) was calculated for CCTA stenosis and FFRCT. The
AUCs were compared by the DeLong method. Pearson’s
and Spearman’s correlation coefficients were calculated to
determine the relationship between FFRCT and FFR.
Bland-Altman analysis was performed with FFR as the
standard of reference. All analyses were performed with
SAS Proprietary Software (version 9.2, SAS Institute, Cary,
North Carolina).
Results
Patient characteristics. One hundred three patients
(100%) who underwent ICA, FFR, CCTA, and blinded
CCTA core laboratory evaluation comprised the study
population. Baseline characteristics are listed in Table 1.
The mean interval between the CCTA and FFR was 2.3
days (range 0 to 26 days), with no adverse events or
revascularization between exams. Six vessels were sub-
totally occluded (99% stenosis), and FFR was not measured
(d
A
(
P
s
s
p
(
t
w
P
w
v
1
m
c
u
p
d
0
D
I
a
a
1992 Koo et al. JACC Vol. 58, No. 19, 2011
Lesion-Specific Ischemia From FFR Computed From CT November 1, 2011:1989–97in these vessels. Of the 159 vessels for which FFR was
performed, maximal stenoses as determined by the CCTA
core lab were: 0% (n 7); 1% to 25% (n 20); 26% to 50%
n  18); 50% to 69% (n  47); and 70% to 98% (n  67).
Diagnostic performance of FFRCT versus CCTA for
iagnosis of ischemia-producing lesions. The FFRCT
applied to coronary vessels resulted in 51 true positives
(32.1%), 83 true negatives (52.2%), 18 false positives
Baseline CharacteristicsTable 1 Baseline Characteristics
Mean age, yrs 62.7 (8.5)
Male 74 (72)
Caucasian (%) 34 (33)
Hypertension 67 (65)
Hyperlipidemia 67 (65)
Diabetes 26 (26)
Mean body-mass index 25.8 (3.5)
Current smoker 24 (36)
Cardiovascular history
Prior myocardial infarction 17 (17)
Prior PCI 16 (16)
Prior CABG 0 (0)
Left ventricular ejection fraction, % 62.3 (5.7)
Vital signs*
Systolic blood pressure, mm Hg 139.1 (17.6)
Diastolic blood pressure, mm Hg 80.9 (11.4)
Heart rate, beats/min 63.9 (8.5)
Laboratory measures
Hemoglobin, mg/dl 14 (1.6)
Hematocrit, % 41.2 (4.3)
Creatinine, mg/dl 0.97 (0.18)
Medications
Aspirin 43 (87.8)
Beta-blocker 54 (96.4)
Nitrate 41 (64.1)
Statins 44 (89.8)
ACE inhibitors 39 (86.7)
Calcium-channel blockers 38 (86.7)
Clopidogrel 79 (94.1)
ARBs 5 (10.2)
Other medication 18 (36.7)
Values are n (%). *At time of coronary computed tomographic angiography.
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker; CABG  coronary
rtery bypass surgery; PCI  percutaneous coronary intervention.
Diagnostic Performance of FFRCT and CCTA on a Per-Vessel and -PTable 2 Diagnostic Performance of FFRCT and CCTA on a Per-V
Per-Vessel
Measure FFRCT <0.80 (95% CI) CCTA Stenosis >50% (9
Accuracy 84.3 (77.7–90.0) 58.5 (50.4–66.2)
Sensitivity 87.9 (76.7–95.0) 91.4 (81.0–97.1)
Specificity 82.2 (73.3–89.1) 39.6 (30.0–49.8)
PPV 73.9 (61.9–83.7) 46.5 (37.1–56.1)
NPV 92.2 (84.6–96.8) 88.9 (75.9–96.3)
LR () 4.94 (3.54–6.89) 1.51 (1.33–1.73)
LR () 0.147 (0.097–0.224) 0.22 (0.127–0.370
For this analysis, a fractional flow reserve or computation of fractional flow reserve from coronary
coronary computed tomographic angiography (CCTA ) stenosis 50% was anatomically obstructive.
CI  confidence interval; LR()  positive likelihood ratio; LR()  negative likelihood ratio; NPV  n(11.3%), and 7 false negatives (4.4%). Diagnostic perfor-
mance of FFRCT and CCTA on a patient- and vessel-based
evaluation are listed in Table 2. Representative examples of
anatomically obstructive stenosis with and without
ischemia-producing stenoses are shown in Figures 1 and 2.
pplying FFRCT values and CCTA stenosis ranges re-
vealed a higher AUC for FFRCT as compared with CCTA
0.90 vs. 0.75, p  0.001) on a lesion-specific basis (Fig. 3).
er-patient performance of FFRCT versus CCTA can be
een in Table 2. A higher AUC for FFRCT was observed,
imilar to per-vessel analyses, as compared with CCTA for
er-patient discrimination (0.92 vs. 0.70, p  0.0001)
Fig. 3). No improvement in AUC was observed on either
he per-vessel and per-patient level when CCTA stenosis
as added to FFRCT (p  0.50 and p  0.64, respectively).
er-vessel diagnostic performance of FFRCT in vessels
ith intermediate stenoses by CCTA. Among the 47
essels with 50% to 69% stenoses by CCTA, 25.5% (n 
2) exhibited ischemia FFR. For these stenoses, FFRCT
demonstrated a diagnostic accuracy, sensitivity, specificity,
PPV, and NPV of 83.0%, 66.7%, 88.6%, 66.7%, and 88.6%.
All 4 “false negative” vessels, where FFRCT did not dem-
onstrate ischemia, had measured FFR values between 0.75
and 0.80.
Correlation of FFRCT to FFR. There was good correla-
tion of per-vessel FFRCT values with FFR values (Spear-
an’s rank correlation  0.717, p  0.0001; Pearson’s
orrelation coefficient  0.678, p  0.0001), with a slight
nderestimation of FFRCT as compared with measured FFR
(mean difference 0.022 0.116, p 0.016) (Figs. 4 and 5) at the
er-vessel level, with similar values and no systematic
ifferences at the per-patient level (mean difference 0.019 
.128, p  0.131).
iscussion
n this prospective multicenter study comparing FFRCT
with CCTA stenosis in patients undergoing ICA and FFR,
the diagnostic accuracy of FFRCT was superior and additive
to CCTA stenosis for the diagnosis of ischemia-causing
lesions as determined by an invasive FFR reference stan-
dard. The FFRCT augmented the discriminatory ability to
t Basisl and -Patient Basis
Per-Patient
I) FFRCT <0.80 (95% CI) CCTA Stenosis >50% (95% CI)
87.4 (79.4–93.1) 61.2 (51.1–70.6)
92.6 (82.1–97.9) 94.4 (84.6–98.8)
81.6 (68.0–91.2) 24.5 (13.3–38.9)
84.7 (73.0–92.8) 58.0 (47.0–68.4)
90.9 (78.3–97.5) 80.0 (51.9–95.7)
5.03 (3.34–7.59) 1.25 (1.11–1.41)
0.091 (0.046–0.181) 0.229 (0.097–0.541)
ted tomographic angiography data (FFRCT) 0.80 was diagnostic of lesion-specific ischemia, andatienesse
5% C
)
compuegative predictive value; PPV  positive predictive value.
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November 1, 2011:1989–97 Lesion-Specific Ischemia From FFR Computed From CTidentify lesions that cause ischemia, as compared with
CCTA stenosis, largely by reducing the rates of false
positive lesions incorrectly classified by stenosis alone.
To our knowledge, this study represents the first of its
kind to evaluate CFD principles applied to CCTA images
for derivation of patient-specific measures of coronary artery
pressure. Importantly, the calculation of FFRCT required no
modification of CCTA acquisition protocols, no additional
imaging, and no additional administration of medications.
The results of the present study establish the feasibility of
CFD modeling for noninvasive determination of the phys-
iological consequences of CAD and support a utility for
application of FFRCT in patients undergoing CCTA.
Coronary computed tomographic angiography is a non-
invasive test for anatomic assessment of CAD severity that
has been suggested as an alternative to ICA (8–10,28). Prior
CCTA studies employing computed tomography scanners
with 64-detector rows have observed a generally high
diagnostic performance of CCTA, as compared with quan-
titative coronary angiography as a reference standard. How-
ever, significant false positive rates underscore a general
overestimation of CAD severity by CCTA, and even among
obstructive CAD lesions identified by CCTA that are
confirmed at ICA, only a minority of such lesions are causal
of ischemia (8,10,11). These findings have also been ob-
Figure 1 Anatomically Obstructive Stenosis With No Functiona
(A) Coronary computed tomography angiography demonstrating obstructive (50%
artery. Proximal and distal to the lesion, there are multiple areas of diffuse calcifie
raphy confirms the obstructive OM stenosis (red arrow). (C) Computation of fracti
onstrates no ischemia in the OM, with a computed value of 0.85. (D) Fractional fl
demonstrates no ischemia in the OM.served for ICA, and prior multicenter studies support a idistinct benefit for adjunctive physiological assessment of
anatomic CAD stenoses by FFR (3,5,6,29). In the FAME
(Fractional Flow Reserve versus Angiography for Multives-
sel Evaluation) study of 1,005 patients with multivessel
CAD, those that underwent FFR-guided revascularization—as
compared with patients undergoing anatomically guided revas-
cularization—experienced lower rates of adverse events, place-
ment of fewer coronary stents, and lower healthcare costs (3,5).
In this regard, the addition of FFRCT to CCTA might
improve clinical decision-making and promote salutatory out-
comes for individuals with CCTA-identified CAD; prospec-
tive outcomes studies are warranted.
We employed definitions identical to those used in the
FAME study for ischemia by FFR (0.80) and obstructive
stenosis by angiography (50%) (3). Prior studies have
demonstrated enhanced specificity for detection of ischemia
when employing an FFR threshold of 0.75 or a stenosis
threshold of 70%, albeit at a penalty of increased false
negatives (30). We examined the relationship of an FFRCT
cutoff of 0.75 and CAD stenosis of 50%, respectively, and
found similar results (data not shown).
One distinction between our study and the FAME study
is how we dealt with subtotal (99%) occlusions. In the
FAME study, these lesions were not subjected to FFR for
reasons of safety and were assigned a value of 0.50 (3). We
emia
osis (white arrow) in the obtuse marginal (OM) branch of the left circumflex
ue of intermediate stenosis severity (40% to 69%). (B) Invasive coronary angiog-
ow reserve from coronary computed tomographic angiography data (FFRCT) dem-
erve (FFR) of 0.84 at the time of invasive coronary angiography similarlyl Isch
) sten
d plaq
onal fl
ow resdentified 6 vessels with subtotal occlusions in our study and
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Lesion-Specific Ischemia From FFR Computed From CT November 1, 2011:1989–97excluded them from the primary analysis to estimate the
most conservative diagnostic performance of FFRCT. As-
signment of a value of 0.50 to FFRCT would necessarily
improve the performance of FFRCT for vessels that would
rarely be clinically interrogated by FFRCT for ischemia. Post
hoc analyses assigning these vessels a value of 0.50 did
expectedly improve diagnostic performance with an accu-
Figure 2 Anatomically Obstructive Stenosis With a Lesion Cau
(A) Multiplanar reformat of coronary computed tomography angiography demonstra
rior descending (LAD) artery. (B) Invasive coronary angiography confirms the LAD s
nary pressure in the first diagonal branch (0.78) and distal LAD (0.58) by FFR. (C)
distal LAD (0.57), demonstrating lesion-specific ischemia of the proximal LAD sten
Figure 3 ROC Demonstrating the AUC for FFRCT and CCTA Ste
Discrimination of Lesions That Cause Ischemia on a P
Areas under the receiver-operator characteristics curve (AUC) on a per-patient (righ
computed tomography angiography (CCTA) stenosis 50% or computation of fract
0.80. ROC  receiver-operator characteristic.racy, sensitivity, specificity, PPV, and NPV of 84.8%,
89.1%, 82.2%, 76.0%, and 92.2%, respectively.
Interestingly, 12 of 47 (25.5%) lesions judged to be of
50% to 69% stenosis severity by CCTA caused ischemia, as
determined by an FFR 0.80. These results are in agree-
ment with prior ICA-FFR studies wherein the magnitude
of stenosis is often discordant with the presence of ischemia
Ischemia
bstructive (50%) stenosis (white arrow) in the proximal portion of the left ante-
is (red arrow) with corresponding hemodynamically significant reductions in coro-
vasive computation of FFR from FFRCT of the first diagonal branch (0.79) and
Abbreviations as in Figure 1.
for the
ssel and -Patient Level
per-vessel (left) level for ischemia by fractional flow reserve 0.80 by coronary
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November 1, 2011:1989–97 Lesion-Specific Ischemia From FFR Computed From CT(31). These patients do not reach an angiographic threshold
for revascularization but, nevertheless, experience ischemia
(32). In these patients, the diagnostic performance of
FFRCT was maintained (accuracy 83.0%), and all 4 false
egative lesions exhibited an invasive FFR value between
.75 and 0.80, suggesting some degree of hemodynamic
ignificance. The ability to noninvasively identify patients
ith ischemia but without high-grade stenoses might allow
Figure 4 Correlation of FFRCT to FFR
A good correlation (R  0.72) is observed. Abbreviations as in Figure 1.
Figure 5 Bland-Altman Plot of FFR and FFRCT on a Per-Vessel B
A slight systematic underestimation of computation of fractional flow reserve from CTor more targeted treatments, and future studies examining
his population should be considered.
We enrolled patients who did as well as did not have a prior
istory of CAD. Diagnostic performance of CCTA for ana-
omic CAD stenosis for patients with known CAD has been
ess robust than for patients with no prior history of CAD
8,9). As such, present Appropriate Use Criteria advocate the
se of CCTA in the low-intermediate likelihood patient with
uspected CAD, but the use of CCTA for patients with
nown CAD is generally considered uncertain or inappropriate
33). The addition of FFRCT to CCTA measures of anatomic
tenosis might enhance the diagnostic accuracy and expand the
tility of CCTA in this population.
The findings of this study are of significant importance.
omputation of FFRCT from CCTAs might permit an
“all-in-one” approach, whereby patient-specific stenosis can
be assessed for lesion-specific ischemia. An FFRCT might
llow for enhanced detection of patients who might benefit
rom revascularization in a manner more specific than
onventional stress perfusion imaging, which might mani-
est abnormalities due to epicardial stenosis or microvascular
isease or both. Furthermore, radiation doses from cardiac
maging has recently been a topic of great discussion, and
he computation of FFRCT from typically acquired CCTA
images negates the need for any additional ionizing radia-
tion while providing combined physiological assessment of
CAD (34). Finally, future evaluation of FFRCT for predic-
tion of hemodynamic improvement after revascularization
or functional assessment of mild diffuse CAD might expand
the clinical indications of this FFRCT technique.
as compared with FFR is observed. Abbreviations as in Figure 1.asis
FFR
t
m
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
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adequately powered to determine the performance of
FFRCT versus CCTA stenosis at the per-vessel rather than
he per-patient level. Establishment of per-patient perfor-
ance of FFRCT versus CCTA will require a greater
number of patients, and we are performing a parallel,
prospective study to address this hypothesis (35). Second,
this study enrolled patients undergoing clinically indicated
ICA and FFR, and thus the ability to assess the diagnostic
performance of FFRCT in all consecutive patients undergo-
ing CCTA is not possible. However, ethical considerations
precluded our performing ICA and FFR in patients for
whom no significant CAD was present. Third, our study
excluded patients with prior CABG, and thus the utility of
FFRCT in this population remains unknown. The FFRCT
should permit evaluation of CABG stenosis, by using the
same principles applied to native coronary arteries, but
future studies will be required to determine its diagnostic
performance in this population.
Conclusions
In this prospective multicenter study, noninvasive FFR
derived from typically acquired CCTA images offers a novel
method that demonstrates high diagnostic performance for
detection and exclusion of coronary artery lesions that cause
ischemia.
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